» Articles » PMID: 36973515

Practice Harmonization Workshops of EBMT: an Expert-based Approach to Generate Practical and Contemporary Guidelines Within the Arena of Hematopoietic Cell Transplantation and Cellular Therapy

Abstract

For hematopoietic cell transplantation (HCT) and cellular therapy (CT), clinical patient care is localized, and practices may differ between countries and from center to center even within the same country. Historically, international guidelines were not always adapted to the changing daily clinical practice and practical topics there were not always addressed. In the absence of well-established guidelines, centers tended to develop local procedures/policies, frequently with limited communication with other centers. To try to harmonize localized clinical practices for malignant and non-malignant hematological disorders within EBMT scope, the practice harmonization and guidelines (PH&G) committee of the EBMT will co-ordinate workshops with topic-specific experts from interested centers. Each workshop will discuss a specific issue and write guidelines/recommendations that practically addresses the topic under review. To provide clear, practical and user-friendly guidelines when international consensus is lacking, the EBMT PH&G committee plans to develop European guidelines by HCT and CT physicians for peers' use. Here, we define how workshops will be conducted and guidelines/recommendations produced, approved and published. Ultimately, there is an aspiration for some topics, where there is sufficient evidence base to be considered for systematic reviews, which are a more robust and future-proofed basis for guidelines/recommendations than consensus opinion.

Citing Articles

In response to: "Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee" by Greco et al.

Howard Jr J, Manzi S, Miljkovic M, Vu T, Mozaffar T EClinicalMedicine. 2024; 78:102918.

PMID: 39640933 PMC: 11617738. DOI: 10.1016/j.eclinm.2024.102918.


Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.

Greco R, Alexander T, Papa N, Muller F, Saccardi R, Sanchez-Guijo F EClinicalMedicine. 2024; 69:102476.

PMID: 38361991 PMC: 10867419. DOI: 10.1016/j.eclinm.2024.102476.


Editorial: Real-world data and real-world evidence in hematologic malignancies.

Malagola M, Ohgami R, Greco R Front Oncol. 2023; 13:1232980.

PMID: 37361576 PMC: 10289287. DOI: 10.3389/fonc.2023.1232980.

References
1.
Hayden P, Sirait T, Koster L, Snowden J, Yakoub-Agha I . An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT. Curr Res Transl Med. 2019; 67(3):79-88. DOI: 10.1016/j.retram.2019.05.002. View

2.
Beauvais D, Bachy E, Baruchel A, Bay J, Caillot D, Cartron G . [Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC]. Bull Cancer. 2021; 108(7-8):725-729. DOI: 10.1016/j.bulcan.2020.10.017. View

3.
Dendoncker C, Brouillat C, Daufrene L, Deledicque V, El Cheikh J, Gibault-Joffe C . [Oral feeding of patient hospitalized for allogeneic stem cells transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2019; 107(1S):S36-S43. DOI: 10.1016/j.bulcan.2019.07.010. View

4.
Alsuliman T, Baylet C, Casabona A, Dann M, De Bentzmann N, Fontoura M . [Sexual and emotional life after allogeneic hematopoietic stem cell transplant: Guidelines and patient booklet from the Francophone Society of Bone marrow Transplant and Cellular therapy (SFGM-TC)]. Bull Cancer. 2020; 107(12S):S151-S158. DOI: 10.1016/j.bulcan.2020.05.012. View

5.
Phelan R, Im A, Hunter R, Inamoto Y, Lupo-Stanghellini M, Rovo A . Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant.... Bone Marrow Transplant. 2022; 57(7):1150-1163. PMC: 10316716. DOI: 10.1038/s41409-022-01591-z. View